GlycoEra AG Alternatives & Competitors
12 companies similar to GlycoEra AG — Advancing Glycan Mediated Therapy
SanegeneBio
Sanegene Bio is committed to advancing transformative RNAi therapies that address global...
Woburn, United States
Replicate Bioscience, Inc.
The Power of RNA Amplified
San Diego, United States
EpiBiologics
Next Generation Protein Degradation
San Mateo, United States
Repertoire Immune Medicines
Repertoire is a biotechnology company creating a new category of immune medicines for canc...
Cambridge, United States
Track all GlycoEra AG competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Topas Therapeutics GmbH
Providing meaningful therapeutic benefit to patients with autoimmune diseases.
Hamburg, Germany
Entelexo Biotherapeutics
Entelexo has created a novel platform technology for engineering exosomes as a new approac...
Irvine, United States
Switch Therapeutics
Developing the next generation of RNAi drugs
San Francisco, United Sta...
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Rockville, United States
Noa Therapeutics
Noa Therapeutics is transforming the treatment of inflammatory barrier diseases.
Toronto, Canada
Seismic Therapeutic
The Machine Learning Immunology Company
Watertown, United States
Montis Biosciences
Pioneering next-gen therapeutics to harness C1q's central role in neuroinflammatory diseas...
Belgium
Rostra Therapeutics
Restore health and save lives through innovative medicines
Glasgow, United Kingdom
About GlycoEra AG
Advancing Glycan Mediated Therapy
Development of precision therapeutics for autoimmune diseases, Selective degradation of pathogenic proteins, Extracellular biologics platform advancement
Patients with autoimmune diseases, Healthcare providers treating autoimmune disorders, Pharmaceutical partners interested in precision immunology
Glycan Mediated Therapy, Autoimmune Disease Treatment, Extracellular Protein Degraders, Targeted Biologics Development, Selective Autoantibody Degradation, Improved Safety Profile Therapies, Early Disease Intervention, BiND™ Platform, Glycoengineering, CustomGlycan Platform, Glycan-Mediated Biology, Biopharmaceutical Development, Therapeutic Product Innovation, CMC Development (Chemistry, Manufacturing, And Controls)
B2B
Licensing, Performance Based, Service Fee
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches GlycoEra AG and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at GlycoEra AG on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
